The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Onychomycosis Treatment Market Progress Between 2026 And 2030?
The onychomycosis treatment market has experienced significant growth in recent years. Its valuation is projected to rise from $3.91 billion in 2025 to $4.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. This historical growth can be attributed to several factors, including the high prevalence of onychomycosis, the limited supply of advanced antifungal medications, increasing public awareness regarding nail hygiene, a rising demand for topical antifungal treatments, and the growing incidence of fungal infections within the elderly population.
The onychomycosis treatment market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $5.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the forecast period include progress in laser and photodynamic therapy technologies, a rise in the use of combination treatment strategies, more telemedicine consultations for dermatological conditions, the broadening of hospital and retail pharmacy distribution channels, and increasing research and development efforts targeting drug-resistant fungal strains. Key trends observed within the forecast period encompass a greater acceptance of combined drug and laser therapies, the increased application of photodynamic therapy for persistent infections, heightened public awareness regarding preventive nail care, the expanded deployment of AI-powered diagnostic tools for fungal infections, and the growing uptake of telemedicine for managing onychomycosis.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp
Which Strong Drivers Are Impacting The Onychomycosis Treatment Market Growth?
The rising prevalence of fungal infections is anticipated to boost the expansion of the onychomycosis treatment market in the future. These infections are microbial diseases originating from various fungi, impacting different body areas or leading to specific health issues. Onychomycosis, a fungal infection of the nails, is commonly addressed using oral antifungal drugs or topical antifungal solutions, aiming to eradicate the fungal growth and encourage healthy nail regeneration. For example, data from May 2025, provided by the UK Health Security Agency, a government body in the UK, indicated that in 2024, bloodstream infection rates caused by yeasts in England had risen by 31% compared to 2015 and by 4% from 2023. Additionally, the period between 2023 and 2024 saw a 4% rise in laboratory-confirmed fungemia cases attributed to yeasts in England, increasing from 2,170 to 2,247 reports. Consequently, the escalating incidence of fungal infections is fueling the expansion of the onychomycosis treatment market.
How Is The Onychomycosis Treatment Market Organized By Segment Classification?
The onychomycosis treatment market covered in this report is segmented –
1) By Type: Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis, Other Types
2) By Treatment Type: Drugs, Laser Therapy, Photodynamic Therapy
3) By Age Group: 0 To 18 Years, 18 To 39 Years, 40 To 64 Years, 65 Years And Above
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
Which Trends Are Contributing To Changes In The Onychomycosis Treatment Market?
Leading companies in the onychomycosis treatment market are concentrating on developing new products, such as MOB-015, and securing their approval from federal agencies to gain a competitive advantage. For example, in June 2023, Moberg Pharma AB, a Sweden-based pharmaceutical firm, received approval for MOB-015 in the European Union to treat mild to moderate fungal nail infections in adults. This authorization from the European Union signifies the initial global marketing clearance for this innovative onychomycosis medication. Two Phase 3 trials supporting MOB-015’s approval demonstrated an improved mycological cure rate (76% versus up to 42% for comparators) and a considerably higher total cure rate compared to the vehicle, all without any serious adverse effects. The topical terbinafine formulation MOB-015 facilitates effective terbinafine concentrations reaching the nail and nail bed, thereby avoiding the systemic exposure risks associated with oral terbinafine treatment.
Who Are The Industry Participants Involved In The Onychomycosis Treatment Market?
Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd.
Get The Full Onychomycosis Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report
Which Region Is The Top Contributor To The Onychomycosis Treatment Market By Share?
North America was the largest region in the onychomycosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Onychomycosis Treatment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report
Browse Through More Reports Similar to the Global Onychomycosis Treatment Market 2026, By The Business Research Company
Onychomycosis Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report
Systemic Aspergillosis And Systemic Candidiasis Market Report
Invasive Fungal Infections Market Report
https://www.thebusinessresearchcompany.com/report/invasive-fungal-infections-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model